Profile data is unavailable for this security.
About the company
Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. It is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions, such as autism. The Company's facility comprises an indoor hydroponic cultivation, proprietary GMP extraction and manufacturing and an analytical and R&D laboratory. It also has a minority interest in early-stage biopharma Kingdom therapeutics. The Company's subsidiary, LVL Health is a medical cannabis clinic for chronic pain that owns a medicines and healthcare products regulatory agency (MHRA) conditionally approved cannabis trial using cannabis-based medicinal products to treat chronic pain in the United Kingdom.
- Revenue in GBP (TTM)130.00k
- Net income in GBP-5.23m
- Incorporated2018
- Employees--
- LocationCeladon Pharmaceuticals PLC32-33 Cowcross StreetLondon EC1M 6DFUnited KingdomGBR
- Phone+44 203 150 0252
- Websitehttps://celadonpharma.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oxford Biodynamics PLC | 617.00k | -11.11m | 3.84m | 45.00 | -- | 1.52 | -- | 6.22 | -0.0643 | -0.0643 | 0.0035 | 0.008 | 0.0487 | 1.20 | 0.379 | 13,711.11 | -87.64 | -39.72 | -114.28 | -45.52 | 41.49 | -- | -1,800.32 | -1,324.62 | 0.6156 | -87.72 | 0.7873 | -- | 231.17 | -15.53 | -61.34 | -- | -1.60 | -- |
| Kanabo Group PLC | 1.14m | -8.18m | 6.32m | 17.00 | -- | 1.07 | -- | 5.55 | -0.013 | -0.013 | 0.0018 | 0.0094 | 0.1054 | 16.28 | 43.85 | 67,058.82 | -75.70 | -75.83 | -81.16 | -83.33 | 7.89 | -- | -718.33 | -1,267.35 | 2.72 | -63.43 | 0.0337 | -- | 48.42 | -- | -16.26 | -- | -- | -- |
| Oncimmune Holdings PLC | 1.21m | -3.14m | 17.27m | 33.00 | -- | -- | -- | 14.22 | -0.0423 | 0.0958 | 0.0164 | -0.0172 | 0.1756 | 1.19 | 0.6917 | 36,787.88 | -45.43 | -- | -- | -- | 63.34 | -- | -258.65 | -- | 1.01 | -0.6511 | 1.32 | -- | -- | -- | -- | -- | -- | -- |
| Celadon Pharmaceuticals PLC | 130.00k | -5.23m | 18.24m | -- | -- | 7.20 | -- | 140.34 | -0.0827 | -0.0827 | 0.002 | 0.0368 | 0.0145 | 26.79 | 0.1194 | -- | -58.39 | -- | -67.06 | -- | -3,433.85 | -- | -4,024.62 | -- | 1.56 | -8.76 | 0.6608 | -- | 212.50 | -- | 58.01 | -- | -- | -- |
| CRUSHMETRIC Group Ltd | 888.99k | -6.74m | 30.16m | 20.00 | -- | 1.62 | -- | 33.92 | -0.0239 | -0.0239 | 0.0034 | 0.0772 | 0.0328 | 6.13 | 15.64 | -- | -25.27 | -25.22 | -31.29 | -56.66 | 73.06 | 41.64 | -771.01 | -200.76 | 0.0273 | -3.18 | 0.0802 | -- | -36.42 | -8.40 | -1,096.05 | -- | -29.47 | -- |
| Eco Animal Health Group Plc | 89.42m | 1.05m | 47.77m | 222.00 | 49.89 | 0.5707 | 9.95 | 0.5342 | 0.0141 | 0.0141 | 1.29 | 1.24 | 0.7312 | 2.63 | 2.98 | 402,801.80 | 1.64 | 4.56 | 2.29 | 6.22 | 42.14 | 45.40 | 2.25 | 5.92 | 2.29 | 7.46 | 0.0413 | 5.37 | 4.82 | 5.86 | 3.97 | -32.08 | 2.71 | -- |
| Venture Life Group PLC | 51.41m | 742.00k | 52.73m | 165.00 | 105.87 | 0.7071 | 5.44 | 1.03 | 0.0039 | 0.0039 | 0.3847 | 0.5869 | 0.4453 | 2.67 | 3.92 | 311,575.80 | 0.6427 | 1.58 | 0.7172 | 1.83 | 39.62 | 40.14 | 1.44 | 3.99 | 1.42 | 2.16 | 0.2215 | 0.00 | 16.89 | 22.33 | 77.12 | 31.30 | 18.85 | -- |
